BEndamustine plus rituximab in first line systemic treatment for extranodal malt lymphoma: Final results of phase ii trial of the spanish lymphoma study group (geltamo)

dc.contributor.author	Bello López, José Luis
dc.date.accessioned	2017-06-07T07:14:24Z
dc.date.available	2017-06-07T07:14:24Z
dc.date.issued	2013
dc.identifier.issn	0278-0232
dc.identifier.uri	http://hdl.handle.net/20.500.11940/4189
dc.language.iso	eng
dc.title	BEndamustine plus rituximab in first line systemic treatment for extranodal malt lymphoma: Final results of phase ii trial of the spanish lymphoma study group (geltamo)
dc.type	Publicación de congreso
dc.authorsophos	Salar, A.
dc.authorsophos	Domingo-Domenech, E.
dc.authorsophos	Panizo, C.
dc.authorsophos	Nicolas, C.
dc.authorsophos	Bargay, J.
dc.authorsophos	Muntanola, A.
dc.authorsophos	Canales, M.
dc.authorsophos	Bello, J. L.
dc.authorsophos	Sancho, J. M.
dc.authorsophos	Tomas, J. F.
dc.authorsophos	Rodriguez, M. J.
dc.authorsophos	Penalver, J.
dc.authorsophos	Palomera, L.
dc.authorsophos	Grande, C.
dc.authorsophos	Sanchez- Blanco, J. J.
dc.authorsophos	Arranz, R.
dc.authorsophos	Conde, E.
dc.authorsophos	Caballero, D.
dc.authorsophos	Montalban, C.
dc.identifier.doi	10.1002/hon.2057
dc.identifier.sophos	14255
dc.journal.title	HEMATOLOGICAL ONCOLOGY
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Hematoloxía clínica
dc.page.initial	129
dc.page.final	130
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	31

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.